Clasado Biosciences has confirmed its attendance at the 13th Microbiome & Probiotics R&D Business Forum, taking place on 28-29 April 2025 in The Hague, The Netherlands. 

R&D Director Dr Lucien Harthoorn will represent Clasado at the event on Monday 28th April, connecting with research professionals and industry leaders at this prestigious forum dedicated to advancing microbiome science and commercial applications. 

The annual event, hosted by bioscience business network Global Engage, brings together academic researchers, clinical experts and industry professionals to explore the latest developments in microbiome research and its applications across various health sectors. The event will run alongside the 7th Skin Microbiome & Cosmeceuticals Congress, creating a comprehensive platform for discussions on the broader applications of microbiome science. 

Dr Harthoorn commented: “The Microbiome & Probiotics R&D Business Forum consistently delivers valuable insights into emerging areas of microbiome science. As the developers behind Bimuno® GOS, the most studied prebiotic galactooligosaccharide on the market, engaging with the research community is fundamental to our continued innovation in this field. We’re particularly interested in the latest research on gut-brain axis communication, personalised nutrition approaches, and advances in translating microbiome research into commercial applications.” 

The forum will cover a diverse range of topics, from gut health and disease to the gut-brain axis, advances in prebiotics, probiotics, synbiotics and postbiotics research, and the challenges of translating research findings into commercial products. The event provides a timely platform for exploring how technological advances can drive innovation in prebiotic science. 

Backed by over 125 scientific publications including more than 20 clinical trials, Clasado’s proprietary galactooligosaccharide (GOS) prebiotic, Bimuno GOS, exemplifies the company’s commitment to evidence-based ingredient development. The company continues to invest in expanding the scientific understanding of prebiotics and their applications across various health areas. 

Those interested in connecting with Dr Harthoorn at the event are encouraged to reach out to Clasado in advance via the Contact form to arrange a meeting. 

To learn more about the 13th Microbiome & Probiotics R&D Business Forum, visit https://global-engage.com/product/microbiome/